A Real-World Study on Safety and Efficacy of TAF Treatment in HBV Patients with High Risk of Osteopo...
A Real-World Study on Safety and Efficacy of TAF Treatment in HBV Patients with High Risk of Osteoporosis or Osteopenia in China
About this item
Full title
Author / Creator
Li, Chunmei , Li, Hui , Gong, Ming , Liu, Yunhua , Zhang, Ruyi , Geng, Jiawei , Wang, Hongyan , Yu, Zhijian , Wang, Zi , Liu, Xiang and Wei, Jia
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Long-term antiviral treatment is necessary for chronic hepatitis B (CHB) patients, and treatment safety is imperative for these patients. Previous studies showed tenofovir alafenamide (TAF) has shown efficacy non-inferior to that of tenofovir disoproxil fumarate (TDF) with improved renal and bone safety. However, there is still a lack of a rapid an...
Alternative Titles
Full title
A Real-World Study on Safety and Efficacy of TAF Treatment in HBV Patients with High Risk of Osteoporosis or Osteopenia in China
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2920571745
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2920571745
Other Identifiers
ISSN
1078-6791
